Document is current
Any future updates will be listed below
-
Authors
Jurin, Ivana
Lucijanić, Marko http://orcid.org/0000-0002-1372-2040
Radonić, Vedran
Letilović, Tomislav
Lucijanić, Jelena
Mesarov, Stjepan
Zagorec, Nikola
Hadžibegović, Irzal
- License Information
-
More Information
Article History
Accepted: 6 February 2021
First Online: 2 March 2021
Declarations
:
: No sources of funding were used to conduct this study or prepare this manuscript.
: IJ and TL have received speaker honoraria from Boehringer Ingelheim. IH has received speaker honoraria from Boehringer Ingelheim, Pfizer, and Bayer. Marko Lucijanić, Vedran Radonić, Jelena Lucijanić, Stjepan Mesarov, and Nikola Zagorec have no conflicts of interest that are directly relevant to the content of this article
: This study was approved by the relevant institutional review boards.
: Not applicable as this was a retrospective study.
: Not applicable.
: Data are available on reasonable request.
: Not applicable as commercial statistical software was used.
: IJ, ML, and IH conceptualized the study and drafted the manuscript. ML performed statistical analysis. All authors participated in data acquisition and interpretation, critical revision of the manuscript, and final approval of the submitted version. All authors agree to be accountable for all aspects of the work.
